Network meta-analysis of antiepileptic drugs in focal drug-resistant epilepsy

Abstract

The results indicate that, based on seizure-free rate and all-cause discontinuation rate, brivaracetam is the most efficacious and acceptable AED, with mild adverse events and acknowledgement of potential publication bias.